Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$3.5M Buy
144,126
+10,656
+8% +$250K ﹤0.01% 2363
2014
Q2
$3.47M Buy
133,470
+17,805
+15% +$454K ﹤0.01% 2302
2014
Q1
$2.77M Sell
115,665
-53,697
-32% -$1.13M ﹤0.01% 2450
2013
Q4
$3.31M Sell
169,362
-36,171
-18% -$728K ﹤0.01% 2280
2013
Q3
$4.34M Sell
205,533
-119,170
-37% -$2.61M ﹤0.01% 1835
2013
Q2
$7.15M Buy
+324,703
New +$7.88M 0.01% 1297

Other funds holding EXC

UBS's EXC Position: Q3 2014 in Review

UBS increased its Exelon (EXC) stake by 29% in Q3 2014, buying an estimated $12.2M and bringing the position to 2,309,944 shares worth $56.2M. The position accounts for 0.04% of the portfolio, ranked #463.

UBS first reported a position in EXC in Q2 2013 and has held it in 6 quarters since. 700 funds tracked by Wall St. Rank hold EXC as of Q3 2014.

  • UBS held 2,309,944 shares of Exelon worth $56.2M as of Q3 2014.
  • UBS bought 521,591 Exelon shares in Q3 2014, an estimated $12.2M.
  • Exelon made up 0.04% of UBS's portfolio in Q3 2014, its #463 holding.
  • UBS first reported a position in Exelon in Q2 2013 and has held it in 6 quarters since.
  • 700 funds tracked by Wall St. Rank held Exelon as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.